Relapsed Follicular Lymphoma
Showing 1 - 8 of 8
Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in United Kingdom (Epcoritamab, Lenalidomide, Rituximab)
Not yet recruiting
- Relapsed Follicular Lymphoma
- Refractory Follicular Lymphoma
- Epcoritamab
- +10 more
-
Aberdeen, United Kingdom
- +24 more
Apr 28, 2023
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total
Active, not recruiting
- Acute Myeloid Leukemia
- +17 more
- Fludarabine
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023
Relapsed Follicular Lymphoma Trial in Italy (ZEVALIN, BEAM)
Active, not recruiting
- Relapsed Follicular Lymphoma
- ZEVALIN
- BEAM
-
Genova, GE, Italy
- +37 more
Dec 22, 2022
Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Boston (TAZEMETOSTAT, Zandelisib)
Not yet recruiting
- Relapsed Follicular Lymphoma
- Refractory Follicular Lymphoma
-
Boston, Massachusetts
- +1 more
Oct 28, 2022
Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Worldwide (Loncastuximab Tesirine, Idelalisib)
Active, not recruiting
- Relapsed Follicular Lymphoma
- Refractory Follicular Lymphoma
- Loncastuximab Tesirine
- Idelalisib
-
Las Vegas, Nevada
- +33 more
Jul 26, 2022
Refractory Follicular Lymphoma, Relapsed Follicular Lymphoma Trial in Washington, Hackensack, Seattle (Ibrutinib, Venetoclax)
Recruiting
- Refractory Follicular Lymphoma
- Relapsed Follicular Lymphoma
-
Washington, District of Columbia
- +2 more
Jul 6, 2022
Relapsed Follicular Lymphoma Trial in Puerto Rico, United States (rituximab, cyclophosphamide, doxorubicin)
Completed
- Relapsed Follicular Lymphoma
- rituximab
- +4 more
-
Muscle Shoals, Alabama
- +42 more
Apr 26, 2013